You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials

Article metrics

Article menu

Download PDFPDF

XML
Interstitial lung disease
Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials

 

Online download statistics by month:

Online download statistics by month: March 2019 to May 2023

AbstractFullPdf
Mar 2019778940
Apr 201910241047418
May 2019797955213
Jun 2019337499185
Jul 2019317409172
Aug 2019266267224
Sep 2019192192180
Oct 2019251235161
Nov 2019243234150
Dec 2019198188150
Jan 202022921489
Feb 2020182172108
Mar 202014113979
Apr 20201009860
May 202013712998
Jun 202014313679
Jul 2020154133118
Aug 202010991157
Sep 202015813171
Oct 2020151138106
Nov 2020847470
Dec 202011194109
Jan 20211039080
Feb 2021118108118
Mar 202112410987
Apr 2021140126103
May 202113913078
Jun 202118317387
Jul 2021143134101
Aug 202113912775
Sep 202116515681
Oct 2021177158118
Nov 202113913684
Dec 2021999274
Jan 202210910499
Feb 202212011054
Mar 202216615850
Apr 202221120153
May 202219318966
Jun 202217115543
Jul 202217916837
Aug 2022225205125
Sep 202219319271
Oct 202221620755
Nov 202224122937
Dec 202223623243
Jan 202337136189
Feb 202339638559
Mar 202335135565
Apr 202327527230
Total10723107265099